Company intelligence / Profile preview

Trimel Pharmaceuticals

Mississauga, Ontario, Canadabloomberg.com ↗

Ownership: Private
Development stage: Other

Overview

Natesto (testosterone nasal gel), formerly CompleoTRT, received FDA approval in May 2014 for testosterone replacement therapy in adult males with hypogonadism. The product offers a novel intranasal route that avoids transference risks associated with topical gels. Other pipeline products included Tefina™ for female orgasmic disorder and various respiratory therapies. Clinical results showed efficacy and safety endpoints were met for Natesto; other programs were at earlier stages or discontinued after rebranding to Acerus[3].

Therapeutic areas: NeurologyPsychiatryPulmonologyMen's HealthWomen's Health
Modalities: Small moleculeHormoneNasal gel drug delivery system
Industry: Biotech

Drug pipeline

1 asset

natesto

Approved

Partnerships

Endo International plc—exclusive license agreement for marketing NATESTO in US/Mexico ($25M upfront + milestones)Aytu BioPharma—distribution/commercialization partnership post-Acerus transition

Beyond the preview

Go deeper on Trimel Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trimel Pharmaceuticals.

Explore the full profile